Voyager Therapeutics, Inc. Total Liabilities and Equity
Voyager Therapeutics, Inc. (VYGR) had Total Liabilities and Equity of $197.75 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-06
- 2026-06-30: Liabilities and Equity $197.75M.
- 2026-03-31: Liabilities and Equity $219.32M.
- 2025-12-31: Liabilities and Equity $252.28M.
- 2025-09-30: Liabilities and Equity $288.31M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $197.75M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $219.32M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $252.28M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $288.31M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $322.10M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $353.24M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $393.05M 10-K · filed 2026-03-09 |
| 2024-09-30 | $426.04M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $436.23M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $469.59M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $351.28M 10-K · filed 2025-03-11 |
| 2023-09-30 | $294.65M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $315.54M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $336.29M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $159.36M 10-K · filed 2024-02-28 |
| 2022-09-30 | $182.48M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $188.60M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $224.18M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $193.85M 10-K · filed 2023-03-07 |
| 2021-09-30 | $184.77M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $208.73M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $237.72M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $261.58M 10-K · filed 2022-03-08 |
| 2020-09-30 | $269.76M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $297.45M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $322.61M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $354.76M 10-K · filed 2021-02-25 |
| 2019-09-30 | $376.22M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $388.59M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $411.35M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $177.03M 10-K · filed 2020-03-03 |
| 2018-09-30 | $197.06M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $214.66M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $235.03M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $184.48M 10-K · filed 2019-02-26 |
| 2017-09-30 | $140.91M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $158.41M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $175.09M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $189.57M 10-K · filed 2018-03-14 |
| 2016-09-30 | $201.98M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $209.81M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $219.98M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $229.46M 10-K · filed 2017-03-15 |
| 2015-09-30 | $166.44M 10-Q · filed 2015-12-17 |
| 2014-12-31 | $11.50M 10-K · filed 2016-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |